Inflammatory Bowel Disease Perspective

 
 
  • Guidelines Reveal Probiotics' Limited Value for GI Conditions   With some exceptions, the evidence to support probiotics is either weak or nonexistent, says Dr David Johnson.
  • Shifting the Target in Ulcerative Colitis: Biologics: Delivering Relief   UCSD physicians explore how biologic treatments can offer relief for many patients with ulcerative colitis, although drug delivery can be difficult for some.
  • 12 Highlights You Should Know From DDW 2020   Although the meeting went virtual this year, it still offered several studies with tangible benefits, according to Dr David Johnson.
  • Shifting the Target in Ulcerative Colitis: Treating to Target   Although ulcerative colitis is a chronic disease, remission can be achieved with effective medication. Experts at UCSD consider disease risks and treatment goals.
  • DDW 2020 Read clinically focused news coverage of key developments from DDW 2020
  • Reassuring Guidance for Managing IBD Patients During COVID-19   Patients with inflammatory bowel disease are probably not at increased risk for the virus but still require careful monitoring, according to Dr David Johnson.
  • A 29-Year-Old Man With Pain When Urinating A 29-year-old man who was previously treated for a urinary tract infection presents with continued pain during urination. What's the cause?
  • Shifting the Target in Ulcerative Colitis: Diagnosing a Debilitating Disease   Ulcerative colitis can be mistaken for other conditions by both patients and physicians. UCSD gastroenterologists discuss methods for accurate diagnosis.
  • Shifting the Target in Ulcerative Colitis   UCSD gastroenterologists discuss the latest developments in the diagnosis and treatment of ulcerative colitis, including the emergence of biologic therapies and new targeted small-molecule drugs.
  • GUILD 2020 Read clinically focused news coverage of key developments from GUILD 2020
  • CCC 2020 Read clinically focused news coverage of key developments from CCC 2020
  • Novel Treatments Are Reshaping Migraine Treatment, Prevention   Dr Christoph Diener on the advantages that ditans, CGRP antagonists, and monoclonal antibodies have over earlier treatments.
  • AIBD 2019 Read clinically focused news coverage of key developments from AIBD 2019
  • From Licorice to Slippery Elm: What Works for GI Symptoms?   In the wake of recent concerns with ranitidine, Dr David Johnson shares the evidence (or lack thereof) for some popular alternative remedies that patients may turn to for upper GI diseases like reflux.
  • The Microbiome: 5 Questions Answered   During this year's Digestive Disease Week, Medscape asked its Instagram followers to submit questions about the microbiome. Dr Alok Patel gets answers to the most popular ones from Dr Colleen Kelly.
  • Personalized Eating: The 'New' Diet? New research is confounding notions of how individuals respond to food, but its rapid commercialization is raising concerns.
  • Is 'Leaky Gut' the Root of All Ills? Investigators are finding that our intestinal mucosal barrier is much more complex than previously thought, and it is potentially at the root of several gastrointestinal disorders.
  • High-Fructose Corn Syrup's Possible Role in Intestinal Cancer   According to Dr David Johnson, a new study provides yet more compelling evidence to call 'time out' on this prevalent food and beverage sweetener.
  • DDW 2019 Read clinically focused news coverage of key developments from DDW 2019
  • A Boy With Frequent Diarrhea: IBS or IBD? Does this 10-year-old boy have inflammatory bowel disease, irritable bowel syndrome, or possibly both?